Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37229461

about

Considerations regarding current diagnosis and prognosis of hepatocellular carcinoma The predictive value of Golgi protein 73 in differentiating benign from malignant liver tumors Golgi protein 73 as a biomarker for hepatocellular carcinoma: A diagnostic meta-analysis.A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma.The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.

P2860

Q28082223-CB7A8A18-C67C-44B2-A654-E366FE9DAF8F Q33916237-A531C076-97E2-41B3-9AB4-CF69924C84E3 Q35159505-504DE561-527B-4AB5-9E4D-6A9C542E1CDD Q37031700-2AF69AF1-6B15-480A-9374-E9FFF1711B58 Q37725466-5BFF924C-6E3E-4F83-B1D6-72C0E389FDD3 Q38600597-248F42F5-7554-4EBC-878C-C268C105C2BF Q45394095-4D250524-9905-4808-A131-6ACE81BBA381 Q47278009-90A07C0C-300D-480C-878B-64C54954F9CF

P2860

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37229461

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum GP73 is complementary to ...... s of hepatocellular carcinoma.

@en

Serum GP73 is complementary to ...... s of hepatocellular carcinoma.

@nl

type

label

Serum GP73 is complementary to ...... s of hepatocellular carcinoma.

@en

Serum GP73 is complementary to ...... s of hepatocellular carcinoma.

@nl

prefLabel

Serum GP73 is complementary to ...... s of hepatocellular carcinoma.

@en

Serum GP73 is complementary to ...... s of hepatocellular carcinoma.

@nl

P1433

Q37229461-3A556C1B-156B-407D-B0FF-BD482E66EE59

P1476

Q37229461-16DE44CF-2743-4240-B6F9-C47976C59309

P2093

Q37229461-03D7FE8F-61FB-43AA-90DB-EEF1C5F635B2

Q37229461-449219B0-BF10-4452-AA46-F477099269AF

Q37229461-53A3DE7B-3CB3-4FC1-BE36-4D5B14F4FEF8

Q37229461-6B9CB9F3-812F-49B1-9BBB-F7F08DF6B1BC

Q37229461-732602A5-9DCB-477D-A673-172A1D75D2B1

Q37229461-74483D8E-6907-461A-AE8A-75072540A713

Q37229461-8C70B8C4-ED74-4EE2-A1D0-19B56F1D19C8

P2860

Q37229461-0D50836A-0283-4CA0-91FC-FCAA429DF77E

Q37229461-1FB22B8F-927A-4DBA-A49E-D0EE3003B67B

Q37229461-2DEA87D9-6EE4-4805-B55E-242A187C2EAE

Q37229461-38D8DD8D-8969-49B7-85D9-2884EEF0211F

Q37229461-39EE96FA-234C-4F21-8DA1-755FFC850599

Q37229461-558115FD-C692-4FD3-B4F8-1655A46FD939

Q37229461-5BD81A31-3AFD-45B7-B249-9742E87F10FB

Q37229461-6021E8D9-B900-47A5-85F1-C301EA6A08F6

Q37229461-6ADED765-2E5F-49D8-9CE7-75D93C3AF8F7

Q37229461-A344A653-4C99-4F3D-91A7-98170B825593

P304

Q37229461-468A376C-A2C5-4FF4-B159-42D66910AB08

P31

Q37229461-2F54582A-2FFC-4510-A5C7-24AA24954D64

P356

Q37229461-FED3C2EA-5810-46CB-8222-F9B1FE572EC9

P433

Q37229461-1A9EA10C-A5B5-4B4A-932D-EC25A94A82C3

P478

Q37229461-82EC1CD2-AF29-445D-AFF6-E86BE840E309

P50

Q37229461-40E22924-0D82-41CF-AC23-E33B20B8232A

P577

Q37229461-138549A8-77A0-4C38-BDB2-8FCDB2392252

P5875

Q37229461-6F630302-F6B2-44C6-9BF4-552F1DD5D0CE

P698

Q37229461-EECCD0D7-A3D3-48E1-9AE7-541F049649DC

P921

Q37229461-4562edf5-5623-4b31-911f-82429fc03289

P932

Q37229461-4EF9CF0F-6FC3-4D7D-B775-7BD19A8E0CCD

P356

P1433

Oncology Letters

P1476

Serum GP73 is complementary to ...... is of hepatocellular carcinoma

@en

P2093

Bu-You Chen

http://www.w3.org/2001/XMLSchema#string

Cui-Hua Lu

http://www.w3.org/2001/XMLSchema#string

Feng Jiang

http://www.w3.org/2001/XMLSchema#string

Run-Zhou Ni

http://www.w3.org/2001/XMLSchema#string

Si-Cong Hou

http://www.w3.org/2001/XMLSchema#string

Wen-Kai Ni

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Li

http://www.w3.org/2001/XMLSchema#string

P2860

GP73, a novel Golgi-localized protein upregulated by viral infection

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

The global burden of cancer: priorities for prevention.

Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.

Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.

Overexpression of α1,6-fucosyltransferase in hepatoma enhances expression of Golgi phosphoprotein 2 in a fucosylation-independent manner.

New perspectives and strategy research biomarkers for hepatocellular carcinoma.

Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.

Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis.

Combined analysis of serum γ-glutamyl transferase isoenzyme II, α-L-fucosidase and α-fetoprotein detected using a commercial kit in the diagnosis of hepatocellular carcinoma.

P304

1152-1158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2013.1522

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258057219

http://www.w3.org/2001/XMLSchema#string

P698

24137480

http://www.w3.org/2001/XMLSchema#string

P921

P932

3796428

http://www.w3.org/2001/XMLSchema#string